预防输血传播传染病措施的国际调查——研究结果2:检测和献血者警惕。

IF 1.6 4区 医学 Q3 HEMATOLOGY
Vox Sanguinis Pub Date : 2025-08-01 Epub Date: 2025-06-04 DOI:10.1111/vox.70056
Galen Conti, Jay Epstein, Silvano Wendel, Claude Tayou Tagny, Antoine Lewin, Divjot Singh Lamba, Lesley Bust, Chancelar Kafere, Jean Stanley, Maria Roussakis, Hany Kamel, Roger Y Dodd, Susan L Stramer
{"title":"预防输血传播传染病措施的国际调查——研究结果2:检测和献血者警惕。","authors":"Galen Conti, Jay Epstein, Silvano Wendel, Claude Tayou Tagny, Antoine Lewin, Divjot Singh Lamba, Lesley Bust, Chancelar Kafere, Jean Stanley, Maria Roussakis, Hany Kamel, Roger Y Dodd, Susan L Stramer","doi":"10.1111/vox.70056","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The results of a global survey on blood safety measures to prevent transfusion-transmitted infectious diseases (TTIDs) were analysed, focusing on TTID testing requirements, practices and associated donor actions (vigilance).</p><p><strong>Materials and methods: </strong>Responses by country/region (C/R) were categorized by World Bank income (WBI) levels: low- and lower middle-income (LLMI), upper middle-income (UMI) and high-income (HI). Consensus responses were used for C/Rs with multiple survey responses. Regions within China and India were analysed separately. Survey questions on TTID testing and donor vigilance were compared across WBI levels.</p><p><strong>Results: </strong>Responses from 74 C/Rs representing 65 countries and Hong Kong were analysed. All C/Rs reported mandatory human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) screening, with a few exceptions for syphilis. Most testing standards were set by national law, using antibody and/or antigen testing for HIV, HBV and HCV; antibody testing was common for syphilis. Nucleic acid testing (NAT) was less common in LLMI than in UMI and HI C/Rs. Confirmatory testing was reported by almost all (96%) C/Rs, often using the same screening test. All C/Rs provided educational material to donors, and deferred/notified donors based on reactive/positive TTID results. Most C/Rs reported reactive/positive results to a central entity, and 89% withdrew and destroyed in-date units from previous collections.</p><p><strong>Conclusion: </strong>All reporting C/Rs screened for HIV, HBV and HCV, with most using confirmatory testing. Advanced tests such as NAT were less common in LLMI C/Rs. Donor vigilance was consistent across income groups, with education, notification and deferral for TTID results, and most reporting withdrawal/destruction of previous collections.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"802-811"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 2: Testing and donor vigilance.\",\"authors\":\"Galen Conti, Jay Epstein, Silvano Wendel, Claude Tayou Tagny, Antoine Lewin, Divjot Singh Lamba, Lesley Bust, Chancelar Kafere, Jean Stanley, Maria Roussakis, Hany Kamel, Roger Y Dodd, Susan L Stramer\",\"doi\":\"10.1111/vox.70056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>The results of a global survey on blood safety measures to prevent transfusion-transmitted infectious diseases (TTIDs) were analysed, focusing on TTID testing requirements, practices and associated donor actions (vigilance).</p><p><strong>Materials and methods: </strong>Responses by country/region (C/R) were categorized by World Bank income (WBI) levels: low- and lower middle-income (LLMI), upper middle-income (UMI) and high-income (HI). Consensus responses were used for C/Rs with multiple survey responses. Regions within China and India were analysed separately. Survey questions on TTID testing and donor vigilance were compared across WBI levels.</p><p><strong>Results: </strong>Responses from 74 C/Rs representing 65 countries and Hong Kong were analysed. All C/Rs reported mandatory human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) screening, with a few exceptions for syphilis. Most testing standards were set by national law, using antibody and/or antigen testing for HIV, HBV and HCV; antibody testing was common for syphilis. Nucleic acid testing (NAT) was less common in LLMI than in UMI and HI C/Rs. Confirmatory testing was reported by almost all (96%) C/Rs, often using the same screening test. All C/Rs provided educational material to donors, and deferred/notified donors based on reactive/positive TTID results. Most C/Rs reported reactive/positive results to a central entity, and 89% withdrew and destroyed in-date units from previous collections.</p><p><strong>Conclusion: </strong>All reporting C/Rs screened for HIV, HBV and HCV, with most using confirmatory testing. Advanced tests such as NAT were less common in LLMI C/Rs. Donor vigilance was consistent across income groups, with education, notification and deferral for TTID results, and most reporting withdrawal/destruction of previous collections.</p>\",\"PeriodicalId\":23631,\"journal\":{\"name\":\"Vox Sanguinis\",\"volume\":\" \",\"pages\":\"802-811\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vox Sanguinis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/vox.70056\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70056","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:分析了预防输血传播传染病(TTIDs)的血液安全措施全球调查的结果,重点是TTIDs检测要求、做法和相关的献血者行动(警惕)。材料和方法:按国家/地区(C/R)的答复按世界银行收入(WBI)水平分类:低收入和中低收入(LLMI)、中高收入(UMI)和高收入(HI)。对于具有多个调查回复的C/ r,采用共识回复。中国和印度的地区分别进行了分析。比较不同WBI水平的TTID检测和供者警惕性的调查问题。结果:分析了来自65个国家和香港的74个C/ r的回应。所有C/Rs都报告了强制性的人类免疫缺陷病毒(HIV)、乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)筛查,梅毒除外。大多数检测标准是由国家法律制定的,使用艾滋病毒、乙型肝炎病毒和丙型肝炎病毒的抗体和/或抗原检测;梅毒的抗体检测很常见。核酸检测(NAT)在LLMI中较UMI和HI C/Rs少见。几乎所有(96%)的C/ r报告了确认试验,通常使用相同的筛选试验。所有C/ r都向捐助者提供教育材料,并根据TTID反应性/阳性结果推迟/通知捐助者。大多数C/ r向中央实体报告了反应性/阳性结果,89%的C/ r从以前的收集中撤回并销毁了过期的设备。结论:所有报告的C/Rs都对HIV、HBV和HCV进行了筛查,其中大多数使用了确证性检测。像NAT这样的高级测试在LLMI C/ r中不太常见。各收入群体的捐助者保持一致的警惕,教育、通知和推迟TTID结果,大多数报告撤回/销毁以前的收款。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 2: Testing and donor vigilance.

Background and objectives: The results of a global survey on blood safety measures to prevent transfusion-transmitted infectious diseases (TTIDs) were analysed, focusing on TTID testing requirements, practices and associated donor actions (vigilance).

Materials and methods: Responses by country/region (C/R) were categorized by World Bank income (WBI) levels: low- and lower middle-income (LLMI), upper middle-income (UMI) and high-income (HI). Consensus responses were used for C/Rs with multiple survey responses. Regions within China and India were analysed separately. Survey questions on TTID testing and donor vigilance were compared across WBI levels.

Results: Responses from 74 C/Rs representing 65 countries and Hong Kong were analysed. All C/Rs reported mandatory human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) screening, with a few exceptions for syphilis. Most testing standards were set by national law, using antibody and/or antigen testing for HIV, HBV and HCV; antibody testing was common for syphilis. Nucleic acid testing (NAT) was less common in LLMI than in UMI and HI C/Rs. Confirmatory testing was reported by almost all (96%) C/Rs, often using the same screening test. All C/Rs provided educational material to donors, and deferred/notified donors based on reactive/positive TTID results. Most C/Rs reported reactive/positive results to a central entity, and 89% withdrew and destroyed in-date units from previous collections.

Conclusion: All reporting C/Rs screened for HIV, HBV and HCV, with most using confirmatory testing. Advanced tests such as NAT were less common in LLMI C/Rs. Donor vigilance was consistent across income groups, with education, notification and deferral for TTID results, and most reporting withdrawal/destruction of previous collections.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vox Sanguinis
Vox Sanguinis 医学-血液学
CiteScore
4.40
自引率
11.10%
发文量
156
审稿时长
6-12 weeks
期刊介绍: Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信